Straits Times Index
3,343.35 +11.65 (+0.35%) S&P 500
5,487.51 +9.61 (+0.18%) Dow
39,184.53 +56.73 (+0.14%) Nasdaq
17,870.64 +65.48 (+0.37%) Bitcoin USD
62,229.31 +496.35 (+0.80%) CMC Crypto 200
1,295.41 +29.27 (+2.31%)
Gaxos.ai Inc. (GXAI)
- GlobeNewswire
Gaxos.AI Successfully Completes Development of AI Solution for Game Developers and Publishers
Roseland, NJ, June 25, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that its gaming division, has successfully completed development of its AI solution for game developers and publishers. “We are extremely pleased with our AI solution. We are providing game developers and publishers the ability to embed a new source of revenue within their games as well as a tool to expedite de
- GlobeNewswire
Gaxos Health Expands Medical Advisory Board
Roseland, NJ, April 25, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that Gaxos Health has expanded its Medical Advisory Board with the appointment of Dr. Eric Margolis and Dr. Jeff Pavell. “The addition of top medical talent to our Medical Advisory Board reflects our continued commitment to pursuing a best-in-class solution for Gaxos Health,” said Vadim Mats, CEO of Gaxos.AI.
- GlobeNewswire
Gaxos.ai Regains Compliance with Nasdaq Listing Requirements
Roseland, NJ, March 26, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. (NASDAQ: GXAI), (“Gaxos” or the “Company”), a company developing artificial intelligence applications across various sectors, announced today that it received written notice from the NASDAQ Stock Market LLC (NASDAQ) on March 22, 2024, informing the Company that it has regained compliance with the minimum bid price requirement under NASDAQ Listing Rule 5550(a)(2) for continued listing on the NASDAQ Capital Market. On July 10, 2023, NA
